GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » Total Long-Term Assets

Atreca (FRA:0C1) Total Long-Term Assets : €1.55 Mil (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Atreca Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Atreca's Total Long-Term Assets for the quarter that ended in Sep. 2023 was €1.55 Mil.

Atreca Total Long-Term Assets Historical Data

The historical data trend for Atreca's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atreca Total Long-Term Assets Chart

Atreca Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Long-Term Assets
Get a 7-Day Free Trial 3.92 17.64 18.86 68.75 72.69

Atreca Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.09 72.69 69.85 67.48 1.55

Atreca Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Atreca Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Atreca's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Atreca (FRA:0C1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » Total Long-Term Assets
Comparable Companies
BRTX VIRI ITRM INTI OGEN ENZN CNSP VRPX BNTC ARAV OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BCEL:USA 0C1:Germany
Address
835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070
Website
https://www.atreca.com
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Atreca (FRA:0C1) Headlines

No Headlines